HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text All Versions of this Article: 2311031007v1 231/1/225    most recent Submit a response View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mayo-Smith, W. W. Articles by Dupuy, D. E. Search for Related Content PubMed PubMed Citation Articles by Mayo-Smith, W. W. Articles by Dupuy, D. E.

Adrenal Neoplasms: CT-guided Radiofrequency Ablation—Preliminary Results¹

¹ From the Department of Radiology, Rhode Island Hospital, Brown Medical School, 593 Eddy St, Providence, RI 02903. From the 2002 RSNA scientific assembly. Received June 27, 2003; revision requested August 26; revision received September 11; accepted October 20. Address correspondence to W.W.M.S. (e-mail: wmayo-smith@lifespan.org).

PURPOSE: To evaluate initial experience with radiofrequency (RF) ablation of adrenal neoplasms.

MATERIALS AND METHODS: Thirteen adrenal masses in 12 patients (bilateral metastases in one patient) were treated with computed tomography (CT)-guided percutaneous RF ablation. Eleven adrenal lesions were metastases (five from lung cancer, four from renal cell carcinoma, and two from melanoma); one lesion was a pheochromocytoma and one was an aldosteronoma. There were 10 men and two women (average age, 58 years; range, 40–77 years) in the study; average adrenal mass diameter was 3.9 cm (range, 1–8 cm). Average number of RF applications per adrenal mass was 2.7 (range, 1–5 applications); average time per application was 7.8 minutes (range, 4–13 minutes). An internally cooled single electrode was used in five sessions; an internally cooled cluster electrode was used in eight sessions.

RESULTS: Average follow-up was 11.2 months (range, 1–46 months). Eleven of 13 lesions were treated successfully with RF ablation after one session. Successful treatment was defined as lack of enhancement of the treated region on follow-up CT images and resolution of the biochemical abnormality in two patients. In two patients with large adrenal lesions (4 and 8 cm in diameter), enhancement of residual tissue was observed after one treatment session; this finding was indicative of residual tumor. One patient with thrombocytopenia that resulted from chemotherapy had a small hematoma, but no transfusion was required. No patient developed hypertension during the RF application. No patient with metastases had recurrent tumor at the treated site, and this lack of recurrence indicated effective local control; 11 patients had progression of metastatic disease at extraadrenal sites.

CONCLUSION: Preliminary data suggest that CT-guided RF ablation is an effective technique for local control of adrenal neoplasms.

© RSNA, 2004

Index terms: Adrenal gland, CT, 86.12112 • Adrenal gland, neoplasms, 86.317, 86.32, 86.328, 86.33 • Computed tomography (CT), guidance • Pheochromocytoma, 86.328 • Radiofrequency (RF) ablation

This article has been cited by other articles:

				G. W. L. Boland, M. A. Blake, P. F. Hahn, and W. W. Mayo-Smith Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization Radiology, December 1, 2008; 249(3): 756 - 775. [Abstract] [Full Text] [PDF]

				Y.-Y. Xiao, J.-L. Tian, and J.-S. Zhang Reply Am. J. Roentgenol., August 1, 2008; 191(2): W75 - W75. [Full Text] [PDF]

				I G C Hermsen, H Gelderblom, J Kievit, J A Romijn, and H R Haak Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma. Eur. J. Endocrinol., June 1, 2008; 158(6): 911 - 919. [Abstract] [Full Text] [PDF]

				S.-Y. Chiou, J.-B. Liu, and L. Needleman Current Status of Sonographically Guided Radiofrequency Ablation Techniques J. Ultrasound Med., April 1, 2007; 26(4): 487 - 499. [Abstract] [Full Text] [PDF]

				E. Liapi and J.-F. H. Geschwind Transcatheter and Ablative Therapeutic Approaches for Solid Malignancies J. Clin. Oncol., March 10, 2007; 25(8): 978 - 986. [Abstract] [Full Text] [PDF]

				I. C. Mitchell and F. E. Nwariaku Adrenal Masses in the Cancer Patient: Surveillance or Excision Oncologist, February 1, 2007; 12(2): 168 - 174. [Abstract] [Full Text] [PDF]

				B. C. Lucey Radiofrequency ablation: the future is now. Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S237 - S240. [Full Text] [PDF]

				J. L. Hinshaw, P. F. Laeseke, T. C. Winter III, M. A. Kliewer, J. P. Fine, and F. T. Lee Jr. Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S306 - S310. [Abstract] [Full Text] [PDF]

				J. R. Haaga, A. A. Exner, Y. Wang, N. T. Stowe, and P. J. Tarcha Combined Tumor Therapy by Using Radiofrequency Ablation and 5-FU-Laden Polymer Implants: Evaluation in Rats and Rabbits Radiology, December 1, 2005; 237(3): 911 - 918. [Abstract] [Full Text] [PDF]

				R. F. Munden, S. S. Swisher, C. W. Stevens, and D. J. Stewart Imaging of the Patient with Non-Small Cell Lung Cancer Radiology, December 1, 2005; 237(3): 803 - 818. [Abstract] [Full Text] [PDF]

				T. Hiraki, K. Yasui, H. Mimura, H. Gobara, T. Mukai, S. Hase, H. Fujiwara, N. Tajiri, Y. Naomoto, T. Yamatsuji, et al. Radiofrequency Ablation of Metastatic Mediastinal Lymph Nodes during Cooling and Temperature Monitoring of the Tracheal Mucosa to Prevent Thermal Tracheal Damage: Initial Experience Radiology, December 1, 2005; 237(3): 1068 - 1074. [Abstract] [Full Text] [PDF]

				C. J. Simon, D. E. Dupuy, and W. W. Mayo-Smith Microwave Ablation: Principles and Applications RadioGraphics, October 1, 2005; 25(suppl_1): S69 - S83. [Abstract] [Full Text] [PDF]

				J. D. Bojarski, D. E. Dupuy, and W. W. Mayo-Smith CT Imaging Findings of Pulmonary Neoplasms After Treatment with Radiofrequency Ablation: Results in 32 Tumors Am. J. Roentgenol., August 1, 2005; 185(2): 466 - 471. [Abstract] [Full Text] [PDF]

				J. Ricke, P. Wust, G. Wieners, S. Hengst, M. Pech, E. L. Hanninen, and R. Felix CT-Guided Interstitial Single-Fraction Brachytherapy of Lung Tumors: Phase I Results of a Novel Technique Chest, June 1, 2005; 127(6): 2237 - 2242. [Abstract] [Full Text] [PDF]

				E. N. Chini, M. J. Brown, M. A. Farrell, and J. W. Charboneau Hypertensive Crisis in a Patient Undergoing Percutaneous Radiofrequency Ablation of an Adrenal Mass Under General Anesthesia Anesth. Analg., December 1, 2004; 99(6): 1867 - 1869. [Abstract] [Full Text] [PDF]

eLetters: